These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 3789256

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differential hepatotoxicity of two oral retinoids (etretinate and isotretinoin) in a patient with palmoplantar psoriasis.
    Vahlquist A, Lööf L, Nordlinder H, Rollman O, Vahlquist C.
    Acta Derm Venereol; 1985; 65(4):359-62. PubMed ID: 2413699
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Successful use of isotretinoin in type Zumbusch generalized pustular psoriasis following recovered etretinate-induced hepatitis].
    Marhold I, Duschet P, Schwarz T, Gschnait F.
    Hautarzt; 1991 Sep; 42(9):580-3. PubMed ID: 1938411
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Methotrexate and etretinate as concurrent therapies in the treatment of psoriasis.
    Zachariae H.
    Arch Dermatol; 1984 Feb; 120(2):155. PubMed ID: 6696467
    [No Abstract] [Full Text] [Related]

  • 7. Methotrexate and etretinate as concurrent therapies in severe psoriasis.
    Vanderveen EE, Ellis CN, Campbell JP, Case PC, Voorhees JJ.
    Arch Dermatol; 1982 Sep; 118(9):660-2. PubMed ID: 7114868
    [Abstract] [Full Text] [Related]

  • 8. Etretinate (Tigason) hepatitis in 2 patients.
    van Voorst Vader PC, Houthoff HJ, Eggink HF, Gips CH.
    Dermatologica; 1984 Sep; 168(1):41-6. PubMed ID: 6698264
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Short-term etretinate for pustular psoriasis.
    Rubin MG, Hanno R.
    J Am Acad Dermatol; 1985 May; 12(5 Pt 1):896-7. PubMed ID: 4008697
    [No Abstract] [Full Text] [Related]

  • 12. Chronic active hepatitis associated with etretinate therapy.
    Weiss VC, Layden T, Spinowitz A, Buys CM, Nemchausky BA, West DP, Emmons KM.
    Br J Dermatol; 1985 May; 112(5):591-7. PubMed ID: 4005158
    [Abstract] [Full Text] [Related]

  • 13. The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study.
    Stern RS, Fitzgerald E, Ellis CN, Lowe N, Goldfarb MT, Baughman RD.
    J Am Acad Dermatol; 1995 Jul; 33(1):44-52. PubMed ID: 7601945
    [Abstract] [Full Text] [Related]

  • 14. Toxic hepatitis due to combination therapy with methotrexate and etretinate in psoriasis.
    Beck HI, Foged EK.
    Dermatologica; 1983 Jul; 167(2):94-6. PubMed ID: 6628806
    [Abstract] [Full Text] [Related]

  • 15. Serial liver biopsies in psoriatic patients receiving long-term etretinate.
    Roenigk HH, Gibstine C, Glazer S, Sparberg M, Yokoo H.
    Br J Dermatol; 1985 Jan; 112(1):77-81. PubMed ID: 3970836
    [Abstract] [Full Text] [Related]

  • 16. Joint pains with psoriasis and long-term systemic etretinate therapy: a case report and summary of 12 cases.
    Ishida Y, Ozawa A, Ohkido M, Imai N.
    J Dermatol; 1993 Oct; 20(10):651-3. PubMed ID: 8277044
    [Abstract] [Full Text] [Related]

  • 17. Liver toxicity of retinoid therapy.
    Roenigk HH.
    Pharmacol Ther; 1989 Oct; 40(1):145-55. PubMed ID: 2645587
    [No Abstract] [Full Text] [Related]

  • 18. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G, Schulze HJ, Färber L, Weidinger G, Steigleder GK.
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.